Page last updated: 2024-08-21

levonorgestrel and drospirenone

levonorgestrel has been researched along with drospirenone in 46 studies

Research

Studies (46)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (2.17)18.2507
2000's10 (21.74)29.6817
2010's33 (71.74)24.3611
2020's2 (4.35)2.80

Authors

AuthorsStudies
Andricopulo, AD; Moda, TL; Montanari, CA1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Hampton, AL; Nie, G; Salamonsen, LA1
Emans, SJ; Pettinato, A1
Suthipongse, W; Taneepanichskul, S1
Sangthawan, M; Taneepanichskul, S1
Bray, JA; Bray, JD; Brown, EL; Ghatge, R; Horwitz, KB; Jacobsen, BM; Jelinsky, S; Lyttle, CR; Richer, JK; Saraf, K; Tunkey, C; Winneker, RC1
Shulman, LP1
Claeys, S; De Bodt, M; Van Cauwenberge, P; Van Lierde, KM1
Tan, JK1
Bertina, RM; Dahm, AE; Helmerhorst, FM; Rosendaal, FR; Rosing, J; Sandset, PM; van Vliet, HA1
Goller, S; Länge, R; Maser, E; Steger-Hartmann, T; Vonk, R; Zeilinger, J1
Cremer, M; Jacobs, A; Phan-Weston, S1
Assmann, A; Dinger, J; Minh, TD; Möhner, S1
Bressler, B; Brophy, JM; Delaney, JA; Etminan, M1
Hernandez, RK; Jick, SS; Parkin, L; Sharples, K1
Hernandez, RK; Jick, SS1
Heinemann, K; Heinemann, LA1
Lidegaard, Ø; Løkkegaard, E; Nielsen, LH; Skjeldestad, FE; Skovlund, CW1
Reid, RL1
Voelker, R1
Bird, ST; Brophy, JM; Delaney, JA; Etminan, M; Liu, X; Pepe, SR1
Jick, S; Pennap, D1
Helmerhorst, FM; Kaptein, AA; Lopez, LM1
Bird, ST; Bressler, B; Brophy, JM; Delaney, JA; Etminan, M; Liu, W1
Bird, ST; Brophy, JM; Delaney, JA; Etminan, M; Hartzema, AG1
Coelingh Bennink, HJ; Ebes, F; Fauser, BC; Wouters, W; Zimmerman, Y1
Kostev, K; Rashed, AN; Ziller, M; Ziller, V1
de Bastos, M; Dekkers, OM; Helmerhorst, FM; Rosendaal, FR; Stegeman, BH; Stijnen, T; Van Hylckama Vlieg, A1
El-Haggar, SM; Mostafa, TM1
Avar, P; Lovas, S; Maasz, G; Pirger, Z; Svigruha, R; Takács, P; Takátsy, A; Tóth, LG; Zrinyi, Z1
Coelingh Bennink, HJ; Foidart, JM; Klipping, C; Maillard, C; Mawet, M; Zimmerman, Y1
Appels, N; Coelingh Bennink, HJ; Duijkers, IJ; Foidart, JM; Jost, M; Klipping, C; Maillard, C; Mawet, M; Zimmerman, Y1
Dinger, J; Heinemann, K; Möhner, S1
Apter, D; Beekman, L; Coelingh Bennink, HJ; Foidart, JM; Maillard, C; Mawet, M; Zimmerman, Y1
Abenhaim, HA; Eberg, M; Eisenberg, MJ; Filion, KB; Joseph, L; Larivée, N; Suissa, S1
Fodor, I; Kiss, T; Lovas, S; Maasz, G; Pirger, Z; Takacs, P; Zrinyi, Z1
Cagnacci, A1
Coulombe, J; Filion, KB; Larivée, N; Suissa, S; Tagalakis, V1
Abe, J; Fukuda, A; Hane, Y; Hasegawa, S; Hatahira, H; Hirade, K; Kinosada, Y; Matsui, T; Motooka, Y; Naganuma, M; Nakamura, M; Sasaoka, S; Takahashi, Y1
Bachelot, A; Dureau, P; Funck-Brentano, C; Germain, M; Hulot, JS; Lebourgeois, B; Salem, JE; Trégouët, DA; Voiriot, P1
Hugon-Rodin, J; Plu-Bureau, G; Sabbagh, E1
Adeyanju, OA; Olatunji, LA1
Bastidas, A; Duijkers, I; Foidart, JM; Jost, M; Klipping, C; Maillard, C; Mawet, M1
Dogné, JM; Douxfils, J; Foidart, JM; Gaspard, U; Jost, M; Morimont, L1

Reviews

6 review(s) available for levonorgestrel and drospirenone

ArticleYear
A review of drospirenone for safety and tolerability and effects on endometrial safety and lipid parameters contrasted with medroxyprogesterone acetate, levonorgestrel, and micronized progesterone.
    Journal of women's health (2002), 2006, Volume: 15, Issue:5

    Topics: Androstenes; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menopause; Progesterone; Women's Health

2006
New developments in hormonal therapy for acne.
    Skin therapy letter, 2007, Volume: 12, Issue:7

    Topics: Acne Vulgaris; Androstenes; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel

2007
Recent innovations in oral contraception.
    Seminars in reproductive medicine, 2010, Volume: 28, Issue:2

    Topics: Acne Vulgaris; Androstenes; Contraception; Contraceptives, Oral, Hormonal; Endometrial Hyperplasia; Estradiol; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperkalemia; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Ovulation; Pregnancy; Randomized Controlled Trials as Topic; Thromboembolism; Uterine Hemorrhage

2010
Oral contraceptives containing drospirenone for premenstrual syndrome.
    The Cochrane database of systematic reviews, 2012, Feb-15, Issue:2

    Topics: Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Premenstrual Syndrome; Randomized Controlled Trials as Topic

2012
Combined oral contraceptives: venous thrombosis.
    The Cochrane database of systematic reviews, 2014, Mar-03, Issue:3

    Topics: Androstenes; Contraceptives, Oral, Combined; Cyproterone; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Pulmonary Embolism; Randomized Controlled Trials as Topic; Venous Thrombosis

2014
Hormonal contraception: venous and arterial disease.
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2017, Volume: 22, Issue:3

    Topics: Adult; Androstenes; Atherosclerosis; Contraceptives, Oral, Synthetic; Female; Humans; Levonorgestrel; Middle Aged; Risk Factors; Venous Thromboembolism

2017

Trials

7 trial(s) available for levonorgestrel and drospirenone

ArticleYear
An open-label randomized comparative study of oral contraceptives between medications containing 3 mg drospirenone/30 microg ethinylestradiol and 150 microg levonogestrel/30 microg ethinylestradiol in Thai women.
    Contraception, 2004, Volume: 69, Issue:1

    Topics: Adolescent; Adult; Androstenes; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Thailand

2004
A comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 microg on premenstrual symptoms.
    Contraception, 2005, Volume: 71, Issue:1

    Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Female; Humans; Levonorgestrel; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome; Regression Analysis; Treatment Outcome

2005
The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive.
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2013, Volume: 18, Issue:6

    Topics: Adult; Analysis of Variance; Androstenes; Contraceptives, Oral, Combined; Cross-Over Studies; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Double-Blind Method; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Prospective Studies; Testosterone

2013
Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives.
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2015, Volume: 20, Issue:6

    Topics: Adolescent; Adult; Alkaline Phosphatase; Androstenes; Aspartate Aminotransferases; Cholesterol, HDL; Cholesterol, LDL; Collagen Type I; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estetrol; Estrogens; Ethinyl Estradiol; Female; gamma-Glutamyltransferase; Growth Hormone; Humans; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Levonorgestrel; Lipid Metabolism; Liver; Mineralocorticoid Receptor Antagonists; Osteocalcin; Peptides; Sex Hormone-Binding Globulin; Triglycerides; Young Adult

2015
Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study.
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2015, Volume: 20, Issue:6

    Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Endometrium; Estetrol; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Mineralocorticoid Receptor Antagonists; Ovarian Follicle; Ovulation; Ovulation Inhibition; Pilot Projects; Pituitary Gland; Progesterone; Ultrasonography; Young Adult

2015
Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA).
    Contraception, 2016, Volume: 94, Issue:4

    Topics: Androstenes; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Estetrol; Estradiol; Female; Humans; Levonorgestrel; Metrorrhagia; Nandrolone

2016
Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone.
    Contraception, 2021, Volume: 103, Issue:4

    Topics: Androstenes; Contraceptives, Oral, Combined; Estetrol; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Sex Hormone-Binding Globulin

2021

Other Studies

33 other study(ies) available for levonorgestrel and drospirenone

ArticleYear
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Progesterone analogues similarly modulate endometrial matrix metalloproteinase-1 and matrix metalloproteinase-3 and their inhibitor in a model for long-term contraceptive effects.
    Molecular human reproduction, 1999, Volume: 5, Issue:4

    Topics: Adult; Androstenes; Cells, Cultured; Collagenases; Contraceptive Agents, Female; Endometrium; Female; Humans; Levonorgestrel; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Pregnenediones; Progesterone; Progesterone Congeners; Stromal Cells; Tissue Inhibitor of Metalloproteinase-1

1999
New contraceptive methods: update 2003.
    Current opinion in pediatrics, 2003, Volume: 15, Issue:4

    Topics: Adolescent; Androstenes; Contraception; Contraceptive Agents; Contraceptive Devices; Contraceptive Devices, Female; Female; Guidelines as Topic; Humans; Levonorgestrel; Male; Medroxyprogesterone Acetate; World Health Organization

2003
Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells.
    The Journal of steroid biochemistry and molecular biology, 2005, Volume: 97, Issue:4

    Topics: Alkaline Phosphatase; Androstenes; Breast Neoplasms; Cell Line, Tumor; Cluster Analysis; Desogestrel; Dose-Response Relationship, Drug; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Levonorgestrel; Ligands; Medroxyprogesterone Acetate; Oligonucleotide Array Sequence Analysis; Progesterone; Progestins; Promegestone; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA; Transcription, Genetic

2005
Response of the female vocal quality and resonance in professional voice users taking oral contraceptive pills: a multiparameter approach.
    The Laryngoscope, 2006, Volume: 116, Issue:10

    Topics: Adult; Androstenes; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Norpregnenes; Phonation; Speech Acoustics; Voice; Voice Disorders; Voice Quality

2006
Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor.
    Journal of thrombosis and haemostasis : JTH, 2008, Volume: 6, Issue:2

    Topics: Activated Protein C Resistance; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Lipoproteins; Middle Aged; Protein S; Thrombophilia

2008
Effects of synthetic gestagens on fish reproduction.
    Environmental toxicology and chemistry, 2009, Volume: 28, Issue:12

    Topics: Androstenes; Animals; Cyprinidae; Female; Gonads; Levonorgestrel; Male; Reproduction; Sperm Motility

2009
Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
    The journal of family planning and reproductive health care, 2010, Volume: 36, Issue:3

    Topics: Adolescent; Adult; Androstenes; Case-Control Studies; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Female; Germany; Humans; Levonorgestrel; Logistic Models; Middle Aged; Mineralocorticoid Receptor Antagonists; Nandrolone; Risk Factors; Venous Thromboembolism; Young Adult

2010
Oral contraceptives and the risk of gallbladder disease: a comparative safety study.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2011, May-17, Volume: 183, Issue:8

    Topics: Adult; Androstenes; Cholecystectomy; Confidence Intervals; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Gallbladder Diseases; Humans; Levonorgestrel; Progestins; Proportional Hazards Models; Retrospective Studies; Risk; Risk Factors

2011
Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database.
    BMJ (Clinical research ed.), 2011, Apr-21, Volume: 342

    Topics: Adolescent; Adult; Age Distribution; Androstenes; Case-Control Studies; Contraceptives, Oral; Contraceptives, Oral, Combined; Estrogens; Female; Humans; Levonorgestrel; Risk Factors; United Kingdom; Venous Thromboembolism; Young Adult

2011
Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data.
    BMJ (Clinical research ed.), 2011, Apr-21, Volume: 342

    Topics: Adolescent; Adult; Age Distribution; Androstenes; Case-Control Studies; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Risk Factors; United States; Venous Thromboembolism; Young Adult

2011
Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel.
    The journal of family planning and reproductive health care, 2011, Volume: 37, Issue:3

    Topics: Androstenes; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Female; Humans; Levonorgestrel; Mineralocorticoid Receptor Antagonists; Risk Assessment; Venous Thromboembolism

2011
Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.
    BMJ (Clinical research ed.), 2011, Oct-25, Volume: 343

    Topics: Adolescent; Adult; Androstenes; Anticoagulants; Cohort Studies; Confounding Factors, Epidemiologic; Contraceptives, Oral; Denmark; Desogestrel; Dose-Response Relationship, Drug; Epidemiologic Methods; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Mineralocorticoid Receptor Antagonists; Norpregnenes; Pregnancy; Time Factors; Venous Thromboembolism; Young Adult

2011
Oral contraceptives and venous thromboembolism: pill scares and public health.
    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2011, Volume: 33, Issue:11

    Topics: Aged; Androstenes; Case-Control Studies; Contraceptives, Oral, Combined; Fear; Female; Humans; Levonorgestrel; Middle Aged; Prospective Studies; Public Health; Retrospective Studies; Risk Factors; Venous Thromboembolism

2011
Risk of blood clots higher for oral contraceptives with certain progestins.
    JAMA, 2011, Nov-23, Volume: 306, Issue:20

    Topics: Androstenes; Contraceptives, Oral; Cyproterone; Denmark; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Progestins; Registries; Risk; Venous Thromboembolism

2011
The association between drospirenone and hyperkalemia: a comparative-safety study.
    BMC clinical pharmacology, 2011, Dec-30, Volume: 11

    Topics: Adult; Androstenes; Cohort Studies; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Hyperkalemia; Levonorgestrel; Logistic Models; Proportional Hazards Models; Retrospective Studies; Risk Factors; Spironolactone

2011
Drospirenone- and levonorgestrel-containing oral contraceptives and the risk of gallbladder disease.
    Contraception, 2012, Volume: 86, Issue:3

    Topics: Adolescent; Adult; Androstenes; Case-Control Studies; Cholecystectomy; Cholecystitis; Contraceptives, Oral; Databases, Factual; Female; Gallbladder Diseases; Humans; Levonorgestrel; Middle Aged; Mineralocorticoid Receptor Antagonists; Odds Ratio; Risk Factors; United Kingdom

2012
Irritable bowel syndrome and drospirenone-containing oral contraceptives; a comparative-safety study.
    Current drug safety, 2012, Volume: 7, Issue:1

    Topics: Adolescent; Adult; Androstenes; Cohort Studies; Contraceptives, Oral, Combined; Databases, Factual; Female; Humans; Incidence; Irritable Bowel Syndrome; Levonorgestrel; Middle Aged; Mineralocorticoid Receptor Antagonists; Proportional Hazards Models; Retrospective Studies; Young Adult

2012
Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?
    Journal of thrombosis and haemostasis : JTH, 2013, Volume: 11, Issue:6

    Topics: Adolescent; Adult; Androstenes; Cohort Studies; Contraceptives, Oral; Databases, Factual; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Proportional Hazards Models; Risk; Time Factors; United States; Venous Thromboembolism; Young Adult

2013
The prescribing of contraceptives for adolescents in German gynecologic practices in 2007 and 2011: a retrospective database analysis.
    Journal of pediatric and adolescent gynecology, 2013, Volume: 26, Issue:5

    Topics: Adolescent; Androstenes; Child; Chlormadinone Acetate; Contraceptive Agents; Desogestrel; Drug Prescriptions; Drug Utilization; Female; Germany; Gynecology; Humans; Levonorgestrel; Menstruation Disturbances; Practice Patterns, Physicians'; Pregnancy; Pregnancy in Adolescence; Retrospective Studies

2013
Drospirenone: more cases of thrombosis than with levonorgestrel.
    Prescrire international, 2013, Volume: 22, Issue:143

    Topics: Adolescent; Adult; Androstenes; Child; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Middle Aged; Thrombosis

2013
Cardiovascular risk in Egyptian healthy consumers of different types of combined oral contraceptives pills: A comparative study.
    Endocrine, 2015, Volume: 49, Issue:3

    Topics: Adiponectin; Adipose Tissue; Adult; Androstenes; Anthropometry; Cardiovascular Diseases; Chemistry, Pharmaceutical; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Cross-Sectional Studies; Drug Combinations; Egypt; Ethinyl Estradiol; Female; Humans; Leptin; Levonorgestrel; Norpregnenes; Resistin; Risk Factors

2015
HPLC-MS/MS analysis of steroid hormones in environmental water samples.
    Drug testing and analysis, 2016, Volume: 8, Issue:1

    Topics: Androstenes; Chromatography, High Pressure Liquid; Environmental Monitoring; Fresh Water; Levonorgestrel; Limit of Detection; Progesterone; Solid Phase Extraction; Tandem Mass Spectrometry; Water Pollutants, Chemical

2016
Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives.
    Contraception, 2016, Volume: 93, Issue:5

    Topics: Adult; Androstenes; Cardiovascular Diseases; Cohort Studies; Contraceptives, Oral, Combined; Ethinyl Estradiol; Europe; Female; Follow-Up Studies; Humans; Incidence; Levonorgestrel; Longitudinal Studies; Mineralocorticoid Receptor Antagonists; Patient Reported Outcome Measures; Pharmacovigilance; Progestins; Proportional Hazards Models; Risk Factors

2016
Drospirenone-containing combined oral contraceptives and the risk of arterial thrombosis: a population-based nested case-control study.
    BJOG : an international journal of obstetrics and gynaecology, 2017, Volume: 124, Issue:11

    Topics: Adolescent; Adult; Androstenes; Case-Control Studies; Contraceptives, Oral, Combined; Drug Administration Schedule; Female; Humans; Levonorgestrel; Middle Aged; Risk Factors; United Kingdom; Venous Thromboembolism; Young Adult

2017
Complex molecular changes induced by chronic progestogens exposure in roach, Rutilus rutilus.
    Ecotoxicology and environmental safety, 2017, Volume: 139

    Topics: Androstenes; Animals; Biomarkers; Brain; Cyprinidae; Ecosystem; Environmental Exposure; Europe; Female; Gonads; Kidney; Lakes; Levonorgestrel; Lipids; Liver; Progesterone; Progestins; Protein Deglycase DJ-1; Receptors, LDL; Vitellogenins; Water Pollutants, Chemical

2017
Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters.
    Drug safety, 2017, Volume: 40, Issue:7

    Topics: Adolescent; Adult; Androstenes; Cohort Studies; Contraceptives, Oral, Combined; Drug Administration Schedule; Female; Humans; Levonorgestrel; Middle Aged; Proportional Hazards Models; Risk Factors; Venous Thromboembolism; Young Adult

2017
Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.
    PloS one, 2017, Volume: 12, Issue:7

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Androstenes; Child; Contraceptives, Oral, Combined; Databases, Factual; Desogestrel; Drug-Related Side Effects and Adverse Reactions; Estrogens; Ethinyl Estradiol; Female; Humans; Japan; Levonorgestrel; Male; Middle Aged; Norethindrone; Norgestrel; Odds Ratio; Progestins; Thromboembolism; Young Adult

2017
Association of Oral Contraceptives With Drug-Induced QT Interval Prolongation in Healthy Nonmenopausal Women.
    JAMA cardiology, 2018, 09-01, Volume: 3, Issue:9

    Topics: Administration, Oral; Adult; Androgen Antagonists; Androstenes; Cohort Studies; Contraceptive Agents, Female; Desogestrel; Europe; Female; Humans; Levonorgestrel; Logistic Models; Long QT Syndrome; Norpregnenes; Sotalol; Young Adult

2018
[Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
    Gynecologie, obstetrique, fertilite & senologie, 2018, Volume: 46, Issue:12

    Topics: Androstenes; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Female; France; Humans; Levonorgestrel; Norpregnenes; Progestins; Risk Factors; Vascular Diseases; Venous Thromboembolism

2018
Drospirenone-containing oral contraceptives do not affect glucose regulation and circulating corticosterone.
    Journal of basic and clinical physiology and pharmacology, 2019, Aug-30, Volume: 30, Issue:5

    Topics: Androstenes; Animals; Blood Glucose; Body Weight; Contraceptives, Oral; Corticosterone; Drug Combinations; Ethinyl Estradiol; Female; Insulin; Insulin-Secreting Cells; Levonorgestrel; Rats

2019
Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone.
    The Journal of clinical endocrinology and metabolism, 2022, 12-17, Volume: 108, Issue:1

    Topics: Contraceptives, Oral, Combined; Estetrol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Thrombin

2022